603368 柳药集团
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)6.55913.50012.27610.68015.030
总资产报酬率 ROA (%)2.2094.3834.0693.6755.318
投入资产回报率 ROIC (%)2.9205.9755.6015.0716.657

边际利润分析
销售毛利率 (%)11.81111.88911.50511.41612.437
营业利润率 (%)5.2995.0154.6724.3955.773
息税前利润/营业总收入 (%)6.4596.2125.8295.5967.026
净利润/营业总收入 (%)4.6124.3563.9843.7414.989

收益指标分析
经营活动净收益/利润总额(%)108.194104.038104.008102.63696.824
价值变动净收益/利润总额(%)-0.008-0.0680.8320.2640.500
营业外收支净额/利润总额(%)0.203-0.0290.0380.2111.412

偿债能力分析
流动比率 (X)1.5431.4911.4891.5511.557
速动比率 (X)1.3151.2921.2621.3421.366
资产负债率 (%)63.36664.96165.79163.42463.232
带息债务/全部投入资本 (%)52.34052.51452.37048.575--
股东权益/带息债务 (%)85.62384.17184.62597.04096.858
股东权益/负债合计 (%)54.41250.53348.76054.22954.454
利息保障倍数 (X)5.6195.1835.0444.6976.005

营运能力分析
应收账款周转天数 (天)182.959165.680151.143143.3900.000
存货周转天数 (天)49.00146.80645.55739.9830.000